Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)
VIEW1
A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects With Neovascular Age-Related Macular Degeneration
1 other identifier
interventional
1,217
2 countries
188
Brief Summary
This study is a phase 3, double-masked, randomized, study of the efficacy and safety of VEGF Trap-Eye in patients with neovascular age-related macular degeneration. Approximately 1200 patients will be randomized in the US and Canada.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Aug 2007
Typical duration for phase_3
188 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2007
CompletedFirst Posted
Study publicly available on registry
August 1, 2007
CompletedStudy Start
First participant enrolled
August 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedResults Posted
Study results publicly available
April 16, 2012
CompletedDecember 28, 2012
December 1, 2012
3.1 years
July 31, 2007
December 16, 2011
December 20, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Patients Who Maintained Vision at Week 52 - Last Observation Carried Forward (LOCF)
Defined "maintenance of vision" as patients who lost fewer than 15 letters in Early Treatment Diabetic Retinopathy Study (ETDRS) letter score compared to baseline.
Baseline and at week 52
Secondary Outcomes (4)
Mean Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - LOCF
Baseline and at week 52
Percentage of Patients Who Gained at Least 15 Letters of Vision in the ETDRS Letter Score in the Study Eye at Week 52 - LOCF.
Baseline and at week 52
Mean Change From Baseline in National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) Total Score at Week 52 - LOCF
Baseline and at Week 52
Mean Change From Baseline in Choroidal Neovascularization (CNV) Area at Week 52 (LOCF)
Baseline and at week 52
Study Arms (4)
ranibizumab 0.5mg Q4
ACTIVE COMPARATORaflibercept injection 2.0mg Q4
EXPERIMENTALaflibercept injection 0.5mg Q4
EXPERIMENTALaflibercept injection 2.0mg Q8
EXPERIMENTALInterventions
Participants received a 0.5mg dose of ranibizumab via intravitreal (IVT) injection every 4 weeks for the first year. Thereafter a dose may be administered as frequently as every 4 weeks, but no less frequently than every 12 weeks.
Participants received a 2.0mg dose of aflibercept injection every 4 weeks for the first year. Thereafter a dose may be administered as frequently as every 4 weeks, but no less frequently than every 12 weeks.
Eligibility Criteria
You may qualify if:
- Signed Informed Consent.
- Men and women ≥ 50 years of age.
- Active primary or recurrent subfoveal CNV lesions secondary to AMD, including juxtafoveal lesions that affect the fovea as evidenced by FA in the study eye.
- Early Treatment Diabetic Retinopathy Study (ETDRS) Best Corrected Visual Acuity (BCVA) of: letter score of 73 to 25 (20/40 to 20/320) in the study eye at 4 meters.
- Willing, committed, and able to return for ALL clinic visits and complete all study-related procedures.
- Able to read, (or, if unable to read due to visual impairment, be read to verbatim by the person administering the informed consent or a family member. See Appendix J.4) understand and willing to sign the informed consent form.
- Key
You may not qualify if:
- Any prior ocular (in the study eye) or systemic treatment or surgery for neovascular AMD except dietary supplements or vitamins.
- Any prior or concomitant therapy with another investigational agent to treat neovascular AMD in the study eye, except dietary supplements or vitamins.
- Any prior treatment with anti-VEGF agents in the study eye.
- Total lesion size \> 12 disc areas (30.5 mm\^2, including blood, scars and neovascularization) as assessed by FA in the study eye.
- Subretinal hemorrhage that is either 50% or more of the total lesion area, or if the blood is under the fovea and is 1 or more disc areas in size in the study eye. (If the blood is under the fovea, then the fovea must be surrounded 270 degrees by visible CNV.)
- Scar or fibrosis, making up \> 50% of total lesion in the study eye.
- Scar, fibrosis, or atrophy involving the center of the fovea.
- Presence of retinal pigment epithelial tears or rips involving the macula in the study eye.
- History of any vitreous hemorrhage within 4 weeks prior to Visit 1 in the study eye.
- Presence of other causes of CNV in the study eye.
- History or clinical evidence of diabetic retinopathy, diabetic macular edema or any other vascular disease affecting the retina,other than AMD, in either eye.
- Prior vitrectomy in the study eye.
- History of retinal detachment or treatment or surgery for retinal detachment in the study eye.
- Any history of macular hole of stage 2 and above in the study eye.
- Any intraocular or periocular surgery within 3 months of Day 1 on the study eye, except lid surgery, which may not have taken place within 1 month of day 1, as long as its unlikely to interfere with the injection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Regeneron Pharmaceuticalslead
- Bayercollaborator
Study Sites (188)
Unknown Facility
Birmingham, Alabama, 35205, United States
Unknown Facility
Birmingham, Alabama, 35223, United States
Unknown Facility
Phoenix, Arizona, 85014, United States
Unknown Facility
Phoenix, Arizona, 85020, United States
Unknown Facility
Tucson, Arizona, 85704, United States
Unknown Facility
Tucson, Arizona, 85710, United States
Unknown Facility
Beverly Hills, California, 90211, United States
Unknown Facility
Campbell, California, 95008, United States
Unknown Facility
Fullerton, California, 92835, United States
Unknown Facility
Glendale, California, 91203, United States
Unknown Facility
Irvine, California, 92697, United States
Unknown Facility
La Jolla, California, 92037, United States
Unknown Facility
Loma Linda, California, 92354, United States
Unknown Facility
Los Angeles, California, 90033, United States
Unknown Facility
Los Angeles, California, 90048, United States
Unknown Facility
Menlo Park, California, 94025, United States
Unknown Facility
Mountain View, California, 94040, United States
Unknown Facility
Oakland, California, 94609, United States
Unknown Facility
Palm Springs, California, 92262, United States
Unknown Facility
Pasadena, California, 91105, United States
Unknown Facility
Poway, California, 92064, United States
Unknown Facility
Sacramento, California, 95819, United States
Unknown Facility
San Diego, California, 92120, United States
Unknown Facility
San Francisco, California, 94107, United States
Unknown Facility
Santa Ana, California, 92705, United States
Unknown Facility
Torrance, California, 90503, United States
Unknown Facility
Ventura, California, 93003, United States
Unknown Facility
Westlake Village, California, 91361, United States
Unknown Facility
Yorba Linda, California, 92887, United States
Unknown Facility
Aurora, Colorado, 80045, United States
Unknown Facility
Denver, Colorado, 80205, United States
Unknown Facility
Denver, Colorado, 80230, United States
Unknown Facility
Bridgeport, Connecticut, 06606, United States
Unknown Facility
Hamden, Connecticut, 06518, United States
Unknown Facility
New Haven, Connecticut, 06510, United States
Unknown Facility
New London, Connecticut, 06320, United States
Unknown Facility
Altamonte Springs, Florida, 32701, United States
Unknown Facility
Boynton Beach, Florida, 33426, United States
Unknown Facility
Fort Lauderdale, Florida, 33351, United States
Unknown Facility
Fort Myers, Florida, 33907, United States
Unknown Facility
Fort Myers, Florida, 33912, United States
Unknown Facility
Gainesville, Florida, 32610, United States
Unknown Facility
Jacksonville, Florida, 32224, United States
Unknown Facility
Miami, Florida, 33136, United States
Unknown Facility
Miami, Florida, 33143, United States
Unknown Facility
Mt. Dora, Florida, 32757, United States
Unknown Facility
Orlando, Florida, 32803, United States
Unknown Facility
Orlando, Florida, 32806, United States
Unknown Facility
Oscala, Florida, 34472, United States
Unknown Facility
Palm Beach Gardens, Florida, 33410, United States
Unknown Facility
Pensacola, Florida, 32503, United States
Unknown Facility
Sarasota, Florida, United States
Unknown Facility
Stuart, Florida, 34994, United States
Unknown Facility
Tampa, Florida, 33612, United States
Unknown Facility
Winter Haven, Florida, 33880, United States
Unknown Facility
Augusta, Georgia, 30909, United States
Unknown Facility
Honolulu, Hawaii, 96813, United States
Unknown Facility
‘Aiea, Hawaii, 96701, United States
Unknown Facility
Oak Brook, Illinois, 60523, United States
Unknown Facility
Fort Wayne, Indiana, 46804, United States
Unknown Facility
Indianapolis, Indiana, 46202, United States
Unknown Facility
Indianapolis, Indiana, 46260, United States
Unknown Facility
Indianapolis, Indiana, 46280, United States
Unknown Facility
New Albany, Indiana, 47150, United States
Unknown Facility
Iowa City, Iowa, 52242-1091, United States
Unknown Facility
Wichita, Kansas, 67214, United States
Unknown Facility
Louisville, Kentucky, 40202, United States
Unknown Facility
Louisville, Kentucky, 40207, United States
Unknown Facility
Paducah, Kentucky, 42001, United States
Unknown Facility
New Orleans, Louisiana, 70115, United States
Unknown Facility
New Orleans, Louisiana, 70121, United States
Unknown Facility
Shreveport, Louisiana, 71105, United States
Unknown Facility
Bangor, Maine, 04401, United States
Unknown Facility
Portland, Maine, 04102, United States
Unknown Facility
Baltimore, Maryland, 21209, United States
Unknown Facility
Baltimore, Maryland, 21287, United States
Unknown Facility
Chevy Chase, Maryland, 20815, United States
Unknown Facility
Hagerstown, Maryland, 21740, United States
Unknown Facility
Towson, Maryland, 21204, United States
Unknown Facility
Boston, Massachusetts, 02111, United States
Unknown Facility
Boston, Massachusetts, 02114, United States
Unknown Facility
Boston, Massachusetts, 02215, United States
Unknown Facility
Boston, Massachusetts, United States
Unknown Facility
Peabody, Massachusetts, 01960, United States
Unknown Facility
Ann Arbor, Michigan, 48105, United States
Unknown Facility
Battle Creek, Michigan, 49015, United States
Unknown Facility
Detroit, Michigan, 48202, United States
Unknown Facility
Grand Rapids, Michigan, 49525, United States
Unknown Facility
Jackson, Michigan, 49201, United States
Unknown Facility
Royal Oak, Michigan, 48073, United States
Unknown Facility
Southfield, Michigan, 48034, United States
Unknown Facility
West Bloomfield, Michigan, 48322, United States
Unknown Facility
Edina, Minnesota, 55435, United States
Unknown Facility
Minneapolis, Minnesota, 55404, United States
Unknown Facility
Rochester, Minnesota, 55905, United States
Unknown Facility
Florissant, Missouri, 63031, United States
Unknown Facility
Kansas City, Missouri, 64108, United States
Unknown Facility
Kansas City, Missouri, 64111, United States
Unknown Facility
Springfield, Missouri, 65804, United States
Unknown Facility
St Louis, Missouri, 63110, United States
Unknown Facility
Missoula, Montana, 59801, United States
Unknown Facility
Lincoln, Nebraska, 68506, United States
Unknown Facility
Omaha, Nebraska, 68131, United States
Unknown Facility
Las Vegas, Nevada, 89144, United States
Unknown Facility
Lawrenceville, New Jersey, 08648, United States
Unknown Facility
New Brunswick, New Jersey, 08901, United States
Unknown Facility
Northfield, New Jersey, 08225, United States
Unknown Facility
Teaneck, New Jersey, 07666, United States
Unknown Facility
Toms River, New Jersey, 08753, United States
Unknown Facility
Albuquerque, New Mexico, 87106, United States
Unknown Facility
Albany, New York, 12206, United States
Unknown Facility
Brooklyn, New York, 11223, United States
Unknown Facility
Lynbrook, New York, 11563, United States
Unknown Facility
New York, New York, 10003, United States
Unknown Facility
New York, New York, 10021, United States
Unknown Facility
New York, New York, 10032, United States
Unknown Facility
Poughkeepsie, New York, 12601, United States
Unknown Facility
Rochester, New York, 14620, United States
Unknown Facility
Rochester, New York, 14642, United States
Unknown Facility
Slingerlands, New York, 12159, United States
Unknown Facility
Syracuse, New York, 13224, United States
Unknown Facility
Asheville, North Carolina, 28803, United States
Unknown Facility
Charlotte, North Carolina, 28210, United States
Unknown Facility
Raleigh, North Carolina, 27607, United States
Unknown Facility
Southern Pines, North Carolina, 28387, United States
Unknown Facility
Winston-Salem, North Carolina, 27157, United States
Unknown Facility
Cincinnati, Ohio, 45202, United States
Unknown Facility
Cincinnati, Ohio, 45242, United States
Unknown Facility
Columbus, Ohio, 43215, United States
Unknown Facility
Toledo, Ohio, 43608, United States
Unknown Facility
Oklahoma City, Oklahoma, 73104, United States
Unknown Facility
Ashland, Oregon, 97520, United States
Unknown Facility
Portland, Oregon, 97210, United States
Unknown Facility
Portland, Oregon, 97227, United States
Unknown Facility
Salem, Oregon, 97302, United States
Unknown Facility
Kingston, Pennsylvania, 18704, United States
Unknown Facility
Philadelphia, Pennsylvania, 19104, United States
Unknown Facility
Philadelphia, Pennsylvania, 19107, United States
Unknown Facility
Philadelphia, Pennsylvania, 19124, United States
Unknown Facility
Pittsberg, Pennsylvania, 15231, United States
Unknown Facility
Pittsburgh, Pennsylvania, 15212, United States
Unknown Facility
Pittsburgh, Pennsylvania, 15213, United States
Unknown Facility
West Mifflin, Pennsylvania, 15122, United States
Unknown Facility
Wyomissing, Pennsylvania, 19610, United States
Unknown Facility
Providence, Rhode Island, 02903-4928, United States
Unknown Facility
Charleston, South Carolina, 29414, United States
Unknown Facility
Columbia, South Carolina, 29223, United States
Unknown Facility
Greenville, South Carolina, 29605, United States
Unknown Facility
West Columbia, South Carolina, 29169, United States
Unknown Facility
Rapid City, South Dakota, 57701, United States
Unknown Facility
Memphis, Tennessee, 38119, United States
Unknown Facility
Memphis, Tennessee, 38120, United States
Unknown Facility
Nashville, Tennessee, 37203, United States
Unknown Facility
Abilene, Texas, 79606, United States
Unknown Facility
Austin, Texas, 78705, United States
Unknown Facility
Corpus Cristi, Texas, 78413, United States
Unknown Facility
Dallas, Texas, 75390, United States
Unknown Facility
DeSoto, Texas, 75115, United States
Unknown Facility
Fort Worth, Texas, 76102, United States
Unknown Facility
Fort Worth, Texas, 76104, United States
Unknown Facility
Galveston, Texas, 77555, United States
Unknown Facility
Houston, Texas, 77030, United States
Unknown Facility
McAllen, Texas, 78503, United States
Unknown Facility
Odessa, Texas, 79761, United States
Unknown Facility
San Antonio, Texas, 78240, United States
Unknown Facility
Salt Lake City, Utah, 84107, United States
Unknown Facility
Salt Lake City, Utah, 84132, United States
Unknown Facility
Burlington, Vermont, 05401, United States
Unknown Facility
Charlottesville, Virginia, 22908, United States
Unknown Facility
Fairfax, Virginia, 22031, United States
Unknown Facility
Richmond, Virginia, 23221, United States
Unknown Facility
Seattle, Washington, 98104, United States
Unknown Facility
Silverdale, Washington, 98383, United States
Unknown Facility
Madison, Wisconsin, 53715, United States
Unknown Facility
Madison, Wisconsin, 58705, United States
Unknown Facility
Milwaukee, Wisconsin, 53226, United States
Unknown Facility
Calgary, Alberta, T3E 7MB, Canada
Unknown Facility
Vancouver, British Columbia, V5Z 3N9, Canada
Unknown Facility
Victoria, British Columbia, V8V 1B3, Canada
Unknown Facility
Halifax, Nova Scotia, B3H 2Y9, Canada
Unknown Facility
London, Ontario, N6A 4G5, Canada
Unknown Facility
Mississauga, Ontario, L4W 1W9, Canada
Unknown Facility
Ottawa, Ontario, K1H8L6, Canada
Unknown Facility
Toronto, Ontario, M4N3M5, Canada
Unknown Facility
Toronto, Ontario, M5C 2T2, Canada
Unknown Facility
Montreal, Quebec, H1T 2M4, Canada
Unknown Facility
Montreal, Quebec, H3A 1A1, Canada
Unknown Facility
Regina, Saskatchewan, S4T 1A5, Canada
Related Publications (3)
Li E, Donati S, Lindsley KB, Krzystolik MG, Virgili G. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2020 May 5;5(5):CD012208. doi: 10.1002/14651858.CD012208.pub2.
PMID: 32374423DERIVEDMoshfeghi DM, Thompson D, Saroj N. Changes in neovascular activity following fixed dosing with an anti-vascular endothelial growth factor agent over 52 weeks in the phase III VIEW 1 and VIEW 2 studies. Br J Ophthalmol. 2020 Sep;104(9):1223-1227. doi: 10.1136/bjophthalmol-2019-315021. Epub 2019 Dec 11.
PMID: 31826853DERIVEDYuzawa M, Fujita K, Wittrup-Jensen KU, Norenberg C, Zeitz O, Adachi K, Wang EC, Heier J, Kaiser P, Chong V, Korobelnik JF. Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration. Ophthalmology. 2015 Mar;122(3):571-8. doi: 10.1016/j.ophtha.2014.09.024. Epub 2014 Nov 6.
PMID: 25439429DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Trials Administrator
- Organization
- Regeneron Pharmaceuticals
Study Officials
- STUDY DIRECTOR
Robert Vitti, MD
Regeneron Pharmaceuticals
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2007
First Posted
August 1, 2007
Study Start
August 1, 2007
Primary Completion
September 1, 2010
Study Completion
July 1, 2011
Last Updated
December 28, 2012
Results First Posted
April 16, 2012
Record last verified: 2012-12